Astal Laboratories share news and announcements
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Last close ₹63.81down ₹4.04 (5.95%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.85.
52-week range of traded prices to 23 Oct 2026
₹60.45Low, 27 Apr 2026₹102.00High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹279 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 28.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 13,208
Astal Laboratories share news and announcements
547 announcements, routine notices left out, newest first. Page 6 of 11.
Dec 2022
20 Dec · Board meeting
Meeting on 23 Dec 2022
Nov 2022
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
19 Oct · Management
19 Oct · Management
19 Oct · Management
19 Oct · Management
14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 014 Oct · Board meeting
Meeting on 18 Oct 20226 Oct · Management
Sep 2022
8 Sep · Reg. 34 (1) Annual Report.
5 Sep · Board meeting
Meeting on 8 Sep 2022: annual general meeting
Aug 2022
5 Aug · Board meeting
Meeting on 11 Aug 2022: quarterly results
Jul 2022
21 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
May 2022
23 May · Board meeting
Meeting on 30 May 2022: quarterly results